Positive News SentimentPositive NewsNASDAQ:BCPC Balchem (BCPC) Stock Price, News & Analysis $167.24 +1.24 (+0.75%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$167.26 +0.01 (+0.01%) As of 04/1/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Balchem Stock (NASDAQ:BCPC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Balchem alerts:Sign Up Key Stats Today's Range$163.06▼$167.3350-Day Range$158.46▼$176.1652-Week Range$137.69▼$186.03Volume183,240 shsAverage Volume123,147 shsMarket Capitalization$5.44 billionP/E Ratio42.55Dividend Yield0.52%Price Target$190.00Consensus RatingModerate Buy Company OverviewBalchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.Read More… Remove Ads Balchem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreBCPC MarketRank™: Balchem scored higher than 85% of companies evaluated by MarketBeat, and ranked 44th out of 188 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingBalchem has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBalchem has only been the subject of 2 research reports in the past 90 days.Read more about Balchem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth10.99% Earnings GrowthEarnings for Balchem are expected to grow by 10.99% in the coming year, from $4.64 to $5.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Balchem is 42.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.Price to Earnings Ratio vs. SectorThe P/E ratio of Balchem is 42.55, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 77.19.Price to Earnings Growth RatioBalchem has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBalchem has a P/B Ratio of 4.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Balchem's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.44% of the float of Balchem has been sold short.Short Interest Ratio / Days to CoverBalchem has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Balchem has recently increased by 11.55%, indicating that investor sentiment is decreasing significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldBalchem has a dividend yield of 0.53%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBalchem has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Balchem is 22.14%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Balchem will have a dividend payout ratio of 16.89% next year. This indicates that Balchem will be able to sustain or increase its dividend.Read more about Balchem's dividend. Sustainability and ESG2.3 / 5Environmental Score-1.54 Percentage of Shares Shorted1.44% of the float of Balchem has been sold short.Short Interest Ratio / Days to CoverBalchem has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Balchem has recently increased by 11.55%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment1.63 News SentimentBalchem has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Balchem this week, compared to 5 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Balchem insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.25% of the stock of Balchem is held by insiders.Percentage Held by Institutions87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Balchem's insider trading history. Receive BCPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter. Email Address BCPC Stock News HeadlinesBalchem (NASDAQ:BCPC) Ticks All The Boxes When It Comes To Earnings GrowthMarch 20, 2025 | finance.yahoo.comSidoti Reaffirms Their Hold Rating on Balchem (BCPC)February 25, 2025 | markets.businessinsider.comNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. April 2, 2025 | Paradigm Press (Ad)Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025February 25, 2025 | globenewswire.comBalchem Is A Great Company, But I'm Still Waiting For A Better EntryFebruary 24, 2025 | seekingalpha.comBalchem Corporation (NASDAQ:BCPC) Q4 2024 Earnings Call TranscriptFebruary 22, 2025 | insidermonkey.comBalchem Corp (BCPC) Q4 2024 Earnings Call Highlights: Record Growth and Strategic AdvancementsFebruary 22, 2025 | gurufocus.comQ4 2024 Balchem Corp Earnings Call TranscriptFebruary 22, 2025 | gurufocus.comSee More Headlines BCPC Stock Analysis - Frequently Asked Questions How have BCPC shares performed this year? Balchem's stock was trading at $162.99 at the beginning of 2025. Since then, BCPC stock has increased by 2.6% and is now trading at $167.24. View the best growth stocks for 2025 here. How were Balchem's earnings last quarter? Balchem Co. (NASDAQ:BCPC) posted its quarterly earnings results on Friday, February, 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by $0.08. The basic materials company earned $240 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a trailing twelve-month return on equity of 11.37%. Does Balchem have any subsidiaries? Balchem subsidiaries include these companies: Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others. How do I buy shares of Balchem? Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Balchem own? Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Record date for 1/17 Dividend12/26/2024Ex-Dividend for 1/17 Dividend12/26/2024Dividend Payable1/17/2025Last Earnings2/21/2025Today4/02/2025Next Earnings (Estimated)5/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Chemicals & allied products Sub-IndustrySpecialty Chemicals Current SymbolNASDAQ:BCPC CIK9326 Webwww.balchem.com Phone(845) 326-5600Fax845-326-5717Employees1,340Year Founded1967Price Target and Rating Average Stock Price Target$190.00 High Stock Price Target$190.00 Low Stock Price Target$190.00 Potential Upside/Downside+13.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.93 Trailing P/E Ratio42.55 Forward P/E Ratio36.04 P/E Growth4.41Net Income$128.48 million Net Margins13.47% Pretax Margin17.45% Return on Equity11.37% Return on Assets8.11% Debt Debt-to-Equity Ratio0.19 Current Ratio1.99 Quick Ratio1.16 Sales & Book Value Annual Sales$953.68 million Price / Sales5.71 Cash Flow$5.54 per share Price / Cash Flow30.17 Book Value$35.37 per share Price / Book4.73Miscellaneous Outstanding Shares32,533,000Free Float32,102,000Market Cap$5.44 billion OptionableOptionable Beta0.63 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:BCPC) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Balchem Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Balchem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.